Could This Marijuana Company Be Acquired at a High Premium?

Hydropothecary Corp. (TSXV:THCX) is an attractive takeover target that should command a premium thanks to its competitive advantages.

| More on:

The cannabis industry has been dominated by recent merger and acquisition (M&A) activity. In 2018, the industry has seen the three largest takeovers in its history take place. The largest of which, Aurora Cannabis Inc.’s (TSX:ACB) $3.2 billion deal for MedReleaf Corp. (TSX:LEAF), which took place just last week.

What is attractive about all the M&A activity are the large premiums being paid.

This has investors scurrying about trying to find the next logical takeover target. But investors, beware! You don’t want to buy in to a company simply because of rumoured takeovers. Not all rumours result in offers, and you can end up holding the bag on an underperformer.

You want to look for a quality company that will be successful, even if rumours of a takeover don’t pan out — a company like Hydropothecary Corp. (TSXV:THCX).

A little background

Hydropothecary is a mid-size regional pot stock with a market capitalization just north of $900 million. It has 22 products over four product lines, including the industry’s first and Canada’s only peppermint cannabis oil sublingual spray. The company is a long-standing player Quebec’s medical marijuana industry.

It was the first to receive its Quebec licence back in 2014 and remains the only company licensed in the cultivation, production, and sale of medical marijuana. The company is also the only licensed producer in Canada that is headquartered in Quebec.

Industry leader

The company is a well-trusted player in the industry. It is renowned for its award-winning, innovative, easy-to-use, and discreet products. As one of Canada’s longest-standing pot companies, it has streamlined operations to become one of Canada’s lowest-cost producers.

Hydropothecary has reduced its cost per gram from $1.78 in 2017 to $0.97 as of end of second quarter in 2018. That is almost a 50% reduction in costs, and it is well positioned to reach profitability.

The company has no debt and plenty of cash on hand to fund expansion. It expects to grow annual production to 25,000 kgs by the end of July and to 108,000 kgs by the end of December.

Landmark deal

In April, the company signed a landmark deal with the Sociétés des alcools du Quebec (SAQ), the provincial retailer that will oversee the province’s recreational cannabis sales. The agreement calls for Hydropothecary to supply 200,000 kgs of cannabis over the next five years.

Did you know that the deal is the largest forward supply contract in the history of the cannabis industry? It is a billion-dollar supply deal.

In the first year, the company expects to supply SAQ with approximately 20,000 kgs of cannabis flower and other oil products. Based on Quebec’s projected recreational supply requirements, Hydropothecary expects to capture 35% of the market share in year one.

Uniquely positioned

Hydropothecary is one of the few pot stocks that actually has a competitive advantage. Its long-standing relationship with the province of Quebec has it uniquely positioned to benefit from the impending marijuana legalization. For the larger industry players looking to make inroads in Quebec, it is the most attractive takeover target.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Mat Litalien has no position in any of the companies listed. 

More on Investing

consider the options
Stocks for Beginners

What’s Ahead for Brookfield Asset Management Stock?

Brookfield Asset Management (TSX:BAM) stock is a good long-term core holding, especially now that it offers a decent dividend yield.

Read more »

grow dividends
Investing

MTY Food Group Stock: How High Could it Go in 2023?

MTY Food Group Inc. (TSX:MTY) stock is trading close to its 52-week high, but it could still rise higher in…

Read more »

Dice engraved with the words buy and sell
Stocks for Beginners

The TSX’s Biggest Losers in January 2023 (Should You Sell?)

While markets have trended up in 2023, the recent natural gas drop has made some energy stocks the TSX's biggest…

Read more »

tsx today
Metals and Mining Stocks

TSX Today: What to Watch for in Stocks on Monday, February 6

TSX investors may remain focused on corporate earnings and new geopolitical developments today.

Read more »

Doctor talking to a patient in the corridor of a hospital.
Investing

TFSA: Healthcare Dividend Stocks Are Perfect for Passive Income

Top healthcare dividend stocks like Extendicare Inc. (TSX:EXE) and others can provide huge passive income in your TFSA.

Read more »

TFSA and coins
Tech Stocks

TFSA: Invest in These 2 Stocks for a Legit Chance at $1 Million

Are you interested in building a $1 million portfolio? Invest $20,000 in these two stocks!

Read more »

edit Person using calculator next to charts and graphs
Investing

The Top TSX Stock on My Watch List Right Now

Here's why Alimentation Couche-Tard (TSX:ATD) remains a top TSX stock that long-term investors seeking growth and yield will want to…

Read more »

Hourglass projecting a dollar sign as shadow
Investing

3 Stocks to Add to Your TFSA ASAP

Given their stable cash flows and solid underlying businesses, these three stocks are excellent additions to your TFSA in this…

Read more »